Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (pinus maritima) bark, pycnogenol

Free Radical Biology and Medicine

Volumn 27, Issue 5-6, 1999, Pages 704-724

  Packer, L ^a   Rimbach, G ^a   Virgili, F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biologic effects of flavonoids; Free radical; Procyanidins; Pycnogenol; Reactive nitrogen species; Reactive oxygen species

Indexed keywords

ANTHOCYANIN; CATECHIN; DIPEPTIDYL CARBOXYPEPTIDASE; EPICATECHIN GALLATE; EPIGALLOCATECHIN; FLAVONOID; FLAVONOL; FREE RADICAL; PHENOL DERIVATIVE; PLANT EXTRACT; POLYPHENOL; PROCYANIDIN; QUERCETIN; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; BIOAVAILABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; BIFLAVONOIDS; CARDIOVASCULAR SYSTEM; CATECHIN; CELLS, CULTURED; FLAVONOIDS; FRANCE; FREE RADICAL SCAVENGERS; GENE EXPRESSION; HUMANS; PLANT EXTRACTS; PLANTS, MEDICINAL; PROANTHOCYANIDINS; VITAMIN E;

PINUS MARITIMA; PINUS PINASTER;

EID: 0032839592     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00090-8     Document Type: Review

References (130)

1. Masquelier J., Michaud J., Laparra J., Dumon M.C. Flavonoides and pycnogenols. Intern. J. Vit. Nutr. Res. 49:1979;307-311.
2. Kollesch J., Nickel D. Antike Heilkunst. Ausgewählte Texte aus den medizinischen Schriften der Griechen und Römer. 1994;Reclam, Stuttgart.
3. Minner, H. Thesaurus Medicaminum. Codex 81, University library, Marburg: 1479.
4. Dragendorff G. Die Heilpfanzen der verschiedenen Völker und Zeiten. Ihre Anwendung, wesentlichen Bestandteile und Geschichte. 1898;Ferd. Enke, Stuttgart.
5. Scientific Consultative Committee of National Defence. On the possibility of relaying on wild plants and animals as a source of nutrition. Part 4, OSA, Helsinki; 1979.
6. Hoppe B. Das Kräuterbuch des Hieronimyus Boch. Wissenschafts-historische Untersuchung. 1969;377-378 Anton Hiesemann, Stuttgart.
7. Chandler F.R., Freeman L., Hooper S.N. Herbal remedies of the maritime indians. J. Ethnopharmacol. 1:1979;49-68.
8. Fielder M. Plant medicine and folklore. 1975;55 Winchester press, New York.
9. Youngken H.W. The drugs of the North American Indian II. Am. J. Pharmacol. 97:1924;257-271.
10. Benthsath A., Rusznyak S., Szent-Gyorgyi A. Vitamin nature of flavones. Nature. 138:1936;798.
11. Drehsen G. From ancient pine bark uses to Pycnogenol. Packer L., Hiramatzu M., Yoshikawa T. Antioxidant food supplements in human health. 1998;311-322 Academic Press, San Diego.
12. Le Tacon, F.; Bonneau, M.; Gelpe, J.; Boisseau, T.; Baradat, P. Dieback of maritime pine in the Landes of Gascogne following the introduction of seed from Iberian peninsula and the exessive cold weather. Revue Forestiere Francaise 46:474-484; 1962-1963.
13. Han, Y. C.; Ryu, K. O.; Lee, K. Y.; Chang, S. O.; Youn, K. S. Research report of the Korean Institute of Forest Genetics. Seoul, Korea, 1987.
14. Blumenthal, M. Whole Foods Magazine, August 1996: 24-26.
15. Masquelier J., Triaud J. Fractionnement des leucoanthocyanes du vin [Fractionation of wine leucoanthocyanidins]. Soc. Pharm. Bordeaux. 104:1965;81-85.
16. Bates-Smith E.C. Phytochemistry of proanthocyanidins. Phytochemistry. 14:1975;1107-1113.
17. Cheynier V., Souquet J.-M., Le Roux E., Guyrot S., Rigaud J. Size separation of condensed tannins by normal phase high performance liquid chromatography. Methods Enzymol. 299:1998;178-184.
18. Goldbohm R.A., Hertog M.G., Brants H.A., van Poppel G., van der Brandt P.A. Consumption of black tea and cancer risk a prospective cohort study . J. Natl. Cancer Inst. 88:1996;93-100.
19. Hertog M.G., Bueno-de Mesquita H.B., Fehily A.M., Sweetnam P.M., Elwood P.C., Kromhout D. Fruit and vegetable consumption and mortality in the Caerphilly study. Cancer Epidemiol. Biomarkers Prev. 5:1996;673-677.
20. Hertog M.G. Epidemiological evidence on potential health properties of flavonoids. Proc. Nutr. Soc. 55:1996;385-397.
21. Steinmetz K.A., Potter J.D. Vegetable, fruit and cancer prevention a review . J. Am. Diet Assoc. 96:1996;1027-1039.
22. Halliwell B. Antioxidants in human health and disease. Ann. Rev. Nutr. 16:1996;33-50.
23. Hertog M.G., Hollman P.H., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr. Cancer. 20:1993;315-347.
24. Hertog M.G., Sweetnam P.M., Fehily A.M., Elwood P.C., Kromhout D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men the Caerphilly study . Am. J. Clin. Nutr. 65:1997;1489-1494.
25. Laparra J., Michaud J., Masquelier J. Etude pharmacocinétique des oligoméres flavonoliques [A pharmacokinetic study on oligomeric flavonoids]. Plant Med. Phytother. 11:1977;1331-1342.
26. Pirasteh, G. Identifizierung und Quantifizierung phenolisher Inhaltsstoffe eines Extraktes aus der Rinde der Meereskiefer. Ph.D. Thesis, Westfälishe Wilhelms Universität; Münster, 1988.
27. Nielsen S.E., Kall M., Justesen U., Schou A., Dragsted L.O. Human absorption and excretion of flavonoid after broccoli consumption. Cancer Lett. 114:1997;173.
28. Hollman P.C.H., de Vries J.H.M., van Leeuven S.D., Mengelers M.J.B., Katan M.B. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr. 62:1995;1276-1282.
29. Hertog M.G.L., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., Giampaoli S., Jansen A., Menotti A., Nedeljkovic S., et al. Flavonoid intake and long term risk of coronary hearth disease and cancer in the seven countries study. Arch. Intern. Med. 155:1995;381-386.
30. Chen H., Tappel A. Vitamin E, selenium, Trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q, β-carotene, canthaxanthine and (+)-catechin protect against oxidative damage to kidney, heath, lung and spleen. Free Radic. Res. 22:1995;177-186.
31. Das N.P. Studies on flavonoid metabolism. Absorption and metabolism of (+)-catechin in man. Biochem. Pharmacol. 20:1971;3435-3445.
32. Weisburger, J. H. Tea antioxidant and health. In: Cadenas, E.; Packer, L. eds. Handbook of antioxidants. New York: Marcel Dekker, 1995:135-149.
33. Hackett A.M., Griffiths L.A., Wermeille M. The quantitative disposition of 3-o-methyl-(+)-[U-14C]catechin in man following oral administration. Xenobiotica. 15:1985;907-914.
34. Lee M.-J., Yang Z.-Y., Li H., Chen L., Sun Y., Gobbo S., Balentine D.A., Yang C.S. Analysis of plasma and urinary tea polyphenols in human subjects. Cancer Epidemiol. Biomarkers Prev. 4:1995;33393.
35. Bourne L.C., Rice-Evans C.A. Detecting and measuring bioavailability of phenolics and flavonoids in humans pharmacokinetics of urinary excretion of dietary ferulic acid . Methods Enzymol. 299:1998;91-106.
36. Rice-Evans C.A., Miller N.J., Pananga G. Structure-antioxidant activity relationship of flavonoids and phenolic acids. Free Radic. Biol. Med. 20:1996;933-956.
37. Uchida S., Edamatsu R., Hiramatsu M., Mori A., Nonaka G.-I., Nishioka I., Niwa M., Ozaki M. Condensed tannins scavenge active oxygen radicals. Med. Sci. Res. 15:1987;831-832.
38. van Jaarsveld H., Kuyl J.M., Schulemburg D.H., Wiid N.M. Effect of flavonoids in the outcome of myocardial mitochondrial ischemia/reperfusion injury. Res. Comm. Mol. Pathol. Pharmacol. 91:1996;65-75.
39. Blazso G., Gabor M., Sibbel R., Rohdewald P. Antiinflammatory and superoxide radical scavenging activities of procyanidins containing extract from the bark of Pinus pinaster Sol. and its fractions. Pharm. Pharmacol. 3:1994;217-220.
40. Virgili F., Kobuchi H., Packer L. Procyanidins extracted from Pinus maritima (Pycnogenol®) scavengers of free radical species and modulators of nitrogen monoxide metabolism in activated murine RAW 264.7 macrophages . Free Radic. Biol. Med. 24:1998;1120-1129.
41. Elstner E.F., Kleber E. Radical Scavenger properties of leucocyanidine. Das N.P. Flavonoids in biology and medicine III current issues in flavonoids research . 1990;227-235 Natl Univ of Singapore Press, Singapore.
42. Noda Y., Anzai K., Mori A., Kohno M., Shinmei M., Packer L. Hydroxyl and superoxide anion radical scavenging activities of natural source of antioxidants using the computerized JES-FR30 ESR spectrometer system. Biochem. Mol. Biol. Internat. 42:1997;35-44.
43. Macrides T.A., Shihata A., Kalafatis N., Wright P.F.A. A comparison of the hydroxyl radical scavenging properties of the shark bile steroid 5-β-scymnol and plant pycnogenols. Biochem. Mol. Biol. Int. 42:1997;1249-1260.
44. Nelson A.B., Lau B.H.S., Ide N., Rong Y. Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation and hydroxyl radical induced DNA damage. Drug Develop. Ind. Med. 24:1998;1-6.
45. Emerit I. Reactive oxygen species, chromosome mutation, and cancer possible role of clastogenic factors in carcinogenesis . Free Radic. Biol. Med. 16:1994;99-109.
46. Staedler J., Schmalix W.A., Doehmer J. Inhibition of biotransformation by nitric oxide (NO) overproduction and toxic consequences. Toxicol. Lett. 82:1995;215-219.
47. van Acker S.A.B.E., Tromp M.N.J.L., Haenen G.R.M.M., van der Vijgh W.J.F., Bast A. Flavonoids as scavenger of nitric oxide radical. Biochem. Biophys. Res. Commun. 214:1995;755-759.
48. Haenen G.R.M.M., Paquay J.B.G., Kothouwer R.E.M., Bast A. Peroxynitrite scavenging of flavonoids. Biochem. Biophys. Res. Commun. 236:1997;591-593.
49. Pannala A.S., Rice-Evans C.A., Halliwell B., Singh S. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem. Biophys. Res. Commun. 232:1997;164-168.
50. Pannala A.S., Razaq R., Halliwell B., Singh S., Rice-Evans C.A. Inhibition of peroxynitrite dependent tyrosine nitration by hydroxycinnamates nitration or electron donation? Free Radic. Biol. Med. 24:1998;594-606.
51. Rong, Y.; Li, L.; Lau, B. H. Pycnogenol protects vascular endothelial cells from t-butyl hydroperoxide induced oxidant injury. Biotechnol. Ther. 5:117-126; 1994-95.
52. Wei Z., Peng Q., Lau B.H.S. Pycnogenol enhances endothelial cell antioxidant defences. Redox. Rep. 3:1997;147-155.
53. Suzuki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:1997;269-285.
54. Pereira C.M., Oliveira C.R. Glutamate toxicity on a PC12 cell line involves glutathione (GSH) depletion and oxidative stress. Free Radic. Biol. Med. 23:1997;637-647.
55. Blazso G., Gabor M., Rohdewald P. Antiinflammatory activities of procyanidin-containing extract from Pinus pinaster Ait. after oral and cutaneous application. Pharmazie. 52:1997;380-382.
56. Ueda T., Ueda T., Armstrong D. Preventive effect of natural and synthetic antioxidants on lipid peroxidation in the mammalian eye. Ophthalm. Res. 28:1996;184-192.
57. Packer L. Interactions among antioxidants in health and disease vitamin E and its redox cycle . Proc. Soc. Expt. Biol. Med. 200:1991;271-276.
58. Jovanovic S.V., Steeken S., Tosic M., Marjanovic B., Simic M.G. Flavonoids as antioxidants. J. Am. Chem. Soc. 116:1994;4846-4851.
59. Buettner G.R. The pecking order of free radicals and antioxidants lipid peroxidation alpha tocopherol and ascorbate. Arch. Biochem. Biophys. 300:1993;535-543.
60. Cossins E., Lee R., Packer L. ESR studies of Vitamin C regeneration, order of reactivity of natural souce phytochemical preparations. Biochem. Mol. Biol. Int. 45:1998;583-598.
61. 2-peroxidase system . FEBS Lett. 422:1998;377-380.
62. Bors W., Michel C., Schikora S. Interaction of flavonoids with ascorbate and determination of univalent redox potential a pulse radiolysis study . Free Radic. Biol. Med. 19:1995;45-52.
63. Virgili F., Kim D., Packer L. Procyanidins extracted from pine bark protect α-tocopherol in ECV 304 endothelial cells challenged by activated RAW 264.7 macrophages role of nitric oxide and peroxynitrite . FEBS Lett. 431:1998;315-318.
64. Sen C.K., Roy S., Packer L. Flow cytometric determination of cellular thiols. Methods Enzymol. 299:1998;247-258.
65. Gabor M., Engi E., Sonkodi S. Die Kapillarwandresistenz und ihre Beeinflussung durch wasserlösliche Flavonderivate bei spontan hypertonischen Ratten. Phlebologie. 22:1993;178-182.
66. Guochang, Z.; Kihlstrom, M.; Arstila, A. Proceedings of the International Society Free Radical Research. Torino (Italy), 1992:31.
67. Cao G., Sofic E., Prior R.L. Antioxidant and prooxidant behavior of flavonoids structure-activity relationships . Free Radic. Biol. Med. 22:1997;749-760.
68. Afanase'ev I.B., Dorozhko A.I., Brodskii A.V., Kostyuk V.A., Potapovich A.I. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol. 38:1989;1763-1769.
69. Nardini M., D'Aquino M., Tomassi G., Gentili V., Di Felice M., Scaccini C. Inhibition of human low-density lipoprotein oxidation by caffeic acid and other hydroxycinnamic acid derivatives. Free Radic. Biol. Med. 19:1995;541-552.
70. Decker D.A. Phenolics prooxidant or antioxidants . Nutr. Rev. 55:1997;396-398.
71. Morel I., Lescoat G., Cillard P., Cillard J. Role of flavonoids and iron chelation in antioxidant action. Methods Enzymol. 234:1994;437-443.
72. Morel, I.; Lescoat, G.; Cogrel, O.; Sergent, O.; Pasdeloup, N.; Brissot, P.; Cillard, P.; J., C. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte culture. Biochem. Pharmacol.45:437-443; 1993.
73. Yoshino M., Murakami K. Interaction of iron with polyphenolic compounds application to antioxidant characterization . Anal. Biochem. 257:1998;40-44.
74. 2+ ions implications for their antioxidant properties . Biochem. J. 330:1998;1173-1178.
75. Maffei Facino R., Carini M., Aldini G., Berti F., Rossoni G., Bombardelli E., Morazzoni P. Procyanidines from Vitis vinifera seeds protect rabbit hearth from ischemia/reperfusion injury antioxidant intervention and/or iron and copper sequestering ability . Planta Medica. 62:1996;495-502.
76. Moini, H.; Arroyo, A.; Vaya, J.; Packer, L. Biofavonoid effects on the mitochondrial respiratory electron transport chain and cytochrome C redox state. Redox Rep (in press).
77. Kuo S.M., Leavitt P.S., Lin C.P. Dietary flavonoids interact with trace metals and affect metallothionein level in human intestinal cells. Biol. Trace Elem. Res. 62:1998;135-153.
78. Fuhr U. Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Saf. 18:1998;251-272.
79. Ameer B., Weintraub R.A. Drug interaction with grapefruit juice. Clin. Pharmacokinet. 33:1997;103-121.
80. Baker M.E., Medlock K.L., Sheehan D.M. Flavonoids inhibit estrogen binding to rat alpha-fetoprotein. Proc. Soc. Exp. Biol. Med. 217:1998;317-321.
81. Piantelli M., Rinelli A., Macri E., Maggiano N., Larocca L.M., Scerrati M., Roselli R., Iacoangeli M., Scambia G., Capelli A., Raneletti F.O. Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer. 71:1993;193-198.
82. Drubaix, I.; Viljanen-Tarifa, E.; Robert, A. M.; Robert, L. Role of glycosoaminoglycans in venous disease. Mode of action of some flavonoid drugs. Pathol. Biol. (Paris) 43:461-470; 1995.
83. Middleton E.J., Kandashwami C. Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharmacol. 43:1992;1167-1179.
84. Baxter N.J., Lilley T.H., Haslam E., Williamson M.P. Multiple interactions between polyphenols and a salivary proline-rich protein repeat result in a complexation and precipitaton. Biochemistry. 36:1997;5566-5577.
85. Haslam E. Polyphenol-protein interaction. Biochem J. 139:1974;285-288.
86. Maffei Facino R., Carini M., Aldini G., Bombardelli E., Morazzoni P., Morelli R. Free radical scavenging action and anti-enzyme acivities of procyanidins from Vitis vinifera. Drug Res. 44:1994;592-601.
87. Kobuchi H., Virgili F., Packer L. Assay of the inducible form of nitric oxide synthase activity effect of flavonoids and plant extracts . Methods Enzymol. 301:1999;503-513.
88. Agullo G., Gamet-Payrastre L., Manenti S., Viala C., Remesy C., Chap H., Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase a comparison with tyrosine kinase and protein kinase C inhibition . Biochem. Pharmacol. 53:1997;1649-1657.
89. Lu L.H., Lee S.S., Huang H.C. Epigallocatechin suppression of proliferation of vascular smooth muscle cells correlation with c-jun and JNK . Br. J. Pharmacol. 124:1998;1227-1237.
90. Wang Z.Y., Das M., Bickers D.R., Mukhatar H. Interaction of epicatechin derived from green tea with rat hepatic cytochrome P-450. Drug Metab. Dispos. 16:1988;98-103.
91. Obermeier M.T., White R.E., Yang C.S. Effect of bioflavonoids on hepatic P450 acitivities. Xenobiotica. 25:1995;575-584.
92. Nakane H., One K. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficienct virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerase. Biochemistry. 29:1992;2841-2945.
93. Moore P.S., Pizza C. Observation on the inhibition of HIV-1 reverse transcriptase by catechin. Biochem. J. 228:1992;717-719.
94. Chu S.C., Hsieh Y.S., Lin J.Y. Inhibitory effects of flavonoids on Moloney murine leukemia virus reverse transcriptase activity. J. Natl. Prod. 55:1992;179-183.
95. Nasani I., Seimiya H., Tsurno T. Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins. Biochem. Biophys. Res. Commun. 249:1998;391-396.
96. Skulachev V.P. Aging is a specific biological function rather than the result of a disorder in complex living systhems biochemical evidence in support of Weismann's hypothesis . Biochemistry. 62:1997;1191-1195.
97. Masquelier J., Patay R., Danon G., Bernard J.-P. A propos de l'action vaso-constrictive et particulierement coronaro-constrictive d'un tannöide du vin. Ann. Pharm. Fr. 42:1960;716-721.
98. Fitzpatrick D.F., Bing B., Rohdewald P. Endothelium dependent vascular effects of Pycnogenol. J. Cardiovasc. Pharmacol. 32:1998;509-515.
99. Fitzpatrick D.F., Hirschfield S.L., Ricci T., Jantzen P., Coffey R.G. Endothelium-dependent vasorelaxation caused by various plant extracts. J. Cardiovasc. Pharmacol. 26:1995;90-95.
100. Herrera M.D., Zarzuelo A., Jimenez J., Marhuenda E., Duarte J. Effects of flavonoids on aortic smooth muscle contractility structure-activity relationship . Gen. Pharmacol. 27:1996;273-277.
101. Putter, M.; Grotemayer, K. H. M.; Wurthwein, G.; Araghi-Nikam, M.; Watson, R. R.; Hosseini, S.; Rohdewald, P. Inhibition of smoking-induced platelet aggregation by Aspirin and Pycnogenol; 1999 submitted.
102. Rohdewald, P. U.S. Patent No. 5,720,956 (U.S.A., 1998).
103. Minuz P., Lechi C., Gaino S., Bonapace S., Fontana L., Garbin U., Paluani F., Cominacini L., Zatti M., Lechi A. Oxidized LDL and reduction of the antiaggregating activity of nitric oxide derived from endothelial cells. Thromb. Haemost. 74:1995;1175-1179.
104. Manach C., Regerat F., Texier O., Agullo G., Demigne C., Remsey C. Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids. Nutr. Res. 16:1996;517-544.
105. Ozaki Y., Yatomi Y., Jinnai Y., Kume S. Effects of genistein, a tyrosin kinase inhibitor, on platelet functions. Genistein attenuates thrombin-induced Ca mobilization in human platelets by affecting polyphosphoinositide turnover. Biochem. Pharmacol. 46:1993;395-403.
106. Tzeng S.H., Ko W.C., Ko F.N., Teng M.C. Inhibition of platelet aggregation by some flavonoids. Thromb. Res. 64:1991;91-100.
107. Inokuchi J.-I., Okabe H., Yamauchi T., Nagamatzu A. Inhibitors of angiotensin converting enzyme in crude drugs. I. Chem. Pharm. Bull. 32:1984;3615-3619.
108. Blazso G., Gaspar R., Gabor M., Ruve H.-J., Rohdewald P. ACE inhibition and hypotensive effect of a procyanidins containing extract from the bark of Pinus pinaster. Sol. Pharm. Pharmacol. Lett. 6:1996;8-11.
109. Inokuchi J.-I., Okabe H., Yamauchi T., Nagamatsu A., Nonaka G.I., Nishioka I. Antihypertensive substance in seeds of Areca carecu. Life Sci. 38:1986;1375-1382.
110. Anderson R.E., Kretzer F.L., Rapp L.M. Free radicals and ocular medicine. Adv. Exp. Med. Biol. 366:1994;73-86.
111. Magnard G., Franck J.-P., Dorne P.-A. Intéret du tetrahydroxy flavanne diol en ophtalmologie. Lyon Med. 4:1970;1-18.
112. Jonadet M., Meunier M.T., Bastide P. Anthocyanosides e xtraits de Vitis vinifera, de Vaccinium myrtillus et Pinus maritimus. Pharm. Belg. 38:1983;41-46.
113. Hay E.D. Cell Biology of extracellular matrix. 1993;39-45 Plenum Press, New York.
114. Tixier J.M., Godeau G., Robert A.M., Hornebeck W. Evidence by in vivo and in vitro studies that binding of Pycnogenols to elastin affects its rate of degradation by elastase. Biochem. Pharmacol. 33:1984;3933-3939.
115. Kuttan R., Donnelly P.V., Di Ferrante N. Collagen treated with (+)-catechin becomes resistant to the action of mammalian collagenase. Experientia. 37:1981;221-223.
116. Pavlovic, P.; Swanson, D. Proceedings of 5th annual meeting of the Oxygen Society. Washington D.C., November 1998:155.
117. Packer L. Oxidants, antioxidants nutrients and the athlete. J. Sport Sci. 15:1997;353-363.
118. Cheshier J.E., Ardestani-Kaboudanian S., Liang B., Araghiniknam M., Chung S., Lane S., Castro A., Watson R.R. Immunomodulation by pycnogenol in retrovirus infected or ethanol fed mice. Life Sci. 58:1996;87-96.
119. Lesourd B.M., Meaume S. Cell mediated immunity changes in ageing, relative importance of cell subpopulation switches and of nutritional factors. Immunol. Lett. 40:1994;235-242.
120. Liu F.J., Zhang Y.X., Lau B.H.S. Pycnogenol enhances immune and haemopoietic functions in senescence-accelerated mice. Cell. Mol. Life Sci. 54:1998;1168-1172.
121. Saito M., Hosoyama H., Ariga T., Kataoka S., Yamaji N. Antiulcer activity of grape seed extract and procyanidins. J. Agric. Food Chem. 46:1998;1460-1464.
122. Pihan G., Regillo C., Szabo S. Free radicals and lipid peroxidation in ethanol- or aspirin- induced gastric mucosal injury. Dig. Dis. Sci. 32:1987;1395-1401.
123. Nathan C., Xie Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:1994;13725-13728.
124. Lin Y.-L., Lin J.-K. (-)-Epigallocathechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kB. Mol. Pharmacol. 52:1997;465-472.
125. Liang P., Pardee A.B. Differential display of eukariotic messanger RNA by means of polymerase chain reaction. Science. 257:1992;967-971.
126. Rubbo H., Darley-Usmar V., Freeman B.A. Nitric oxide regulation of tissue free radical injury. Chem. Res. Toxicol. 9:1996;809-820.
127. Yamada K., Noda Y., Nakayama S., Komori Y., Sugihara H., Haegawa T., Nabeshima T. Role of Nitric oxide in learning and memory in monoamine metabolismin the rat brain. Brit J. Pharmacol. 115:1995;852-858.
128. Pogun S., Kumar M.J. Regulation of neurotransmitter reuptake by nitric oxide. Ann. N.Y. Acad. Sci. 738:1994;305-315.
129. Schmidt H.H.H.W., Walter U. NO at work. Cell. 78:1994;919-925.
130. Ingram D.K., Shimada A., Spangler E.L., Ikari H., Hengemihle J., Kuo H., Greig N. Cognitive enhancement. New strategies for stimulating cholinergic, glutaminergic, and nitric oxide system. Ann. NY Acad. Sci. 786:1996;348-361.